Zosano Pharma Corporation is a biotechnology business based in the US. Zosano Pharma Corporation shares (ZSAN) are listed on the NASDAQ and all prices are listed in US Dollars. Zosano Pharma Corporation employs 45 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Zosano Pharma Corporation
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ZSAN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- ZSAN shares summary
- Compare share dealing platforms
- Is ZSAN stock a buy or sell?
- Stock performance over time
- Can I short ZSAN shares?
- Zosano Pharma Corporation's financials
- How volatile are ZSAN shares?
- Does Zosano Pharma Corporation pay a dividend?
- Have ZSAN shares ever split?
- Other common questions
Zosano Pharma Corporation stock price (NASDAQ: ZSAN)Use our graph to track the performance of ZSAN stocks over time.
Zosano Pharma Corporation shares at a glance
|Latest market close||$0.60|
|52-week range||$0.33 - $1.91|
|50-day moving average||$0.68|
|200-day moving average||$0.80|
|Wall St. target price||$2.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.32|
Buy Zosano Pharma Corporation shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Zosano Pharma Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Zosano Pharma Corporation price performance over time
|1 week (2021-10-19)||-4.46%|
|1 month (2021-09-27)||-20.95%|
|3 months (2021-07-27)||-19.57%|
|6 months (2021-04-27)||-35.62%|
|1 year (2020-10-26)||43.75%|
|2 years (2019-10-25)||-72.48%|
|3 years (2018-10-26)||3.63|
|5 years (2016-10-26)||0.6006|
Zosano Pharma Corporation financials
|Gross profit TTM||$-21,569,000|
|Return on assets TTM||-37.4%|
|Return on equity TTM||-101%|
|Market capitalisation||$68.7 million|
TTM: trailing 12 months
Shorting Zosano Pharma Corporation shares
There are currently 4.8 million Zosano Pharma Corporation shares held short by investors – that's known as Zosano Pharma Corporation's "short interest". This figure is 5.8% down from 5.1 million last month.
There are a few different ways that this level of interest in shorting Zosano Pharma Corporation shares can be evaluated.
Zosano Pharma Corporation's "short interest ratio" (SIR)
Zosano Pharma Corporation's "short interest ratio" (SIR) is the quantity of Zosano Pharma Corporation shares currently shorted divided by the average quantity of Zosano Pharma Corporation shares traded daily (recently around 934716.05415861). Zosano Pharma Corporation's SIR currently stands at 5.17. In other words for every 100,000 Zosano Pharma Corporation shares traded daily on the market, roughly 5170 shares are currently held short.
However Zosano Pharma Corporation's short interest can also be evaluated against the total number of Zosano Pharma Corporation shares, or, against the total number of tradable Zosano Pharma Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Zosano Pharma Corporation's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Zosano Pharma Corporation shares in existence, roughly 40 shares are currently held short) or 0.0429% of the tradable shares (for every 100,000 tradable Zosano Pharma Corporation shares, roughly 43 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Zosano Pharma Corporation.
Find out more about how you can short Zosano Pharma Corporation stock.
Zosano Pharma Corporation share dividends
We're not expecting Zosano Pharma Corporation to pay a dividend over the next 12 months.
Have Zosano Pharma Corporation's shares ever split?
Zosano Pharma Corporation's shares were split on a 1:20 basis on 25 January 2018. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Zosano Pharma Corporation shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Zosano Pharma Corporation shares which in turn could have impacted Zosano Pharma Corporation's share price.
Zosano Pharma Corporation share price volatility
Over the last 12 months, Zosano Pharma Corporation's shares have ranged in value from as little as $0.3275 up to $1.91. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Zosano Pharma Corporation's is 3.4989. This would suggest that Zosano Pharma Corporation's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Zosano Pharma Corporation overview
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. .
Zosano Pharma Corporation in the news
ZOSANO PHARMA CORP : Change in Directors or Principal Officers, Other Events (form 8-K)
Zosano Pharma Granted Type C Meeting with FDA Regarding NDA Resubmission for M207 Following Preliminary Top-Line Pharmacokinetic Study Results
ZOSANO PHARMA CORP : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
Frequently asked questionsWhat percentage of Zosano Pharma Corporation is owned by insiders or institutions?
Currently 0.503% of Zosano Pharma Corporation shares are held by insiders and 14.528% by institutions. How many people work for Zosano Pharma Corporation?
Latest data suggests 45 work at Zosano Pharma Corporation. When does the fiscal year end for Zosano Pharma Corporation?
Zosano Pharma Corporation's fiscal year ends in December. Where is Zosano Pharma Corporation based?
Zosano Pharma Corporation's address is: 34790 Ardentech Court, Fremont, CA, United States, 94555 What is Zosano Pharma Corporation's ISIN number?
Zosano Pharma Corporation's international securities identification number is: US98979H2022 What is Zosano Pharma Corporation's CUSIP number?
Zosano Pharma Corporation's Committee on Uniform Securities Identification Procedures number is: 98979H103
More guides on Finder
How to buy ProShares Bitcoin Strategy ETF (BITO)
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
How to buy The Real Good Food Company (RGF) stock when it goes public
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
How to buy Lulu’s Fashion Lounge Holdings (LVLU) stock when it goes public
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
How to buy Allarity Therapeutics (ALLR) stock when it goes public
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
How to buy Jupiter Neurosciences (JUNS) stock when it goes public
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
How to buy Mainz Biomed (MYNZ) stock when it goes public
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
How to buy Progressive Care stock when it goes public
Everything we know about the Progressive Care IPO, plus information on how to buy in.
How to buy Desert Peak Minerals (DPM) stock when it goes public
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
How to buy Vaxxinity (VAXX) stock when it goes public
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
How to buy Entrada Therapeutics (TRDA) stock when it goes public
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
Ask an Expert